Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Pacira: Q1 Earnings Snapshot

Pacira: Q1 Earnings Snapshot

PCRX : 21.06 (-2.77%)
Pacira: Q4 Earnings Snapshot

Pacira: Q4 Earnings Snapshot

PCRX : 21.06 (-2.77%)
Pacira: Q3 Earnings Snapshot

Pacira: Q3 Earnings Snapshot

PCRX : 21.06 (-2.77%)
Pacira: Q2 Earnings Snapshot

Pacira: Q2 Earnings Snapshot

PCRX : 21.06 (-2.77%)
Pacira: Q1 Earnings Snapshot

Pacira: Q1 Earnings Snapshot

PCRX : 21.06 (-2.77%)
Pacira: Q4 Earnings Snapshot

Pacira: Q4 Earnings Snapshot

PCRX : 21.06 (-2.77%)
Pacira: Q3 Earnings Snapshot

Pacira: Q3 Earnings Snapshot

PCRX : 21.06 (-2.77%)
Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022

-- EXPAREL average daily sales for July 2022 were 105 percent of July 2021 -- TAMPA, Fla., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences,...

PCRX : 21.06 (-2.77%)
NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communities About Non-Opioid Options to Manage Pain

-- Multi-year initiative will leverage NFL Alumni events and educational opportunities to raise awareness about effective opioid alternatives --...

PCRX : 21.06 (-2.77%)
Pacira BioSciences Reports Second Quarter 2022 Financial Results

-- Second quarter revenue of $169 million, increased 25% over prior year, demonstrating successful integration and synergies from Flexion acquisition –--...

PCRX : 21.06 (-2.77%)

Barchart Exclusives

Up 77% YTD, This Cathie Wood Stock Could Have More Upside Potential
This crypto-focused stock just got a new bull note that has absolutely nothing to do with its crypto exposure. Should you invest? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar